Takefumi Komiya

Takefumi Komiya

Takefumi Komiya

Clinical Associate Professor

Department of Medicine

Jacobs School of Medicine & Biomedical Sciences


Specialty/Research Focus

Immunotherapy; Lung; Medical Oncology

Contact Information
100 High St
Suite D2-76
Buffalo, New York 14203
takefumi@buffalo.edu


Patient Care

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD


Professional Summary:

My previous efforts and accomplishments illustrate continuing interest in lung cancer research. My initial training in Japan as a pulmonary physician gave me the opportunity to learn lung cancer management. Although I had already achieved a faculty position in Japan, I planned to become a physician scientist in the US in the field of thoracic oncology. I finally obtained a faculty position in 2013 to conduct clinical and research activity at The University of Kansas Medical Center.

I will continue to work in this field. I have experience in translational research. I will try to develop a novel treatment in lung cancer by conducting investigator-initiated trials (IITs) with immunotherapy and others in thoracic oncology. I will also work on population and hospital based data research in oncology.

Education and Training:

  • Fellowship, Medical Oncology, National Institutes of Health, National Cancer Institute (2013)
  • Residency, Internal medicine, Howard University (2010)
  • PhD, Medicine, Kindai University (2005)
  • Other, Visiting (Research) Fellow, National Cancer Institute (2003)
  • MD, Medicine, Kagoshima University (1990)

Employment:

  • Assistant Professor, Internal Medicine, Kindai University
  • Assistant Professor, Internal Medicine, Tulane University
  • Assistant Professor, Internal Medicine, University of Kansas
  • Clinical Associate Professor, Internal Medicine, University at Buffalo

Awards and Honors:

  • Appreciation Award by President, (2019)
  • Conquer Cancer Foundation of ASCO Merit Award (2013)
  • Resident of Year (2010)
  • Kindai University Medical Award (2003)

Research Expertise:

  • Database Analysis: NCDB, NCI-SEER
  • Investigator-initiated trial
  • Lung Cancer: Treatment of Lung Cancer

Grants and Sponsored Research:

  • Phase I/II study of Atezolizumab in combination with pirfenidone in immunotherapy-refractory non-small cell lung cancer
    Genentech
    Role: Principal Investigator
  • Phase I study of epacadostat (INCB24360) in combination with sirolimus in advanced malignancy
    Incyte
    Role: Principal Investigator
    $500,000

Journal Articles:

See all (25 more)

Professional Memberships:

  • ASCO, AACR, IASLC; American Society of Clinical Oncology, American Association for Cancer Research, International Association for the Study of Lung Cancer

Presentations:

  • "Genomic medicine in US." Seminar at Osaka Habikino Medical Center, Osaka, Japan. Oct 31, 2019. (2019)
  • "Targeting mTOR signaling to enhance immunotherapy in lung cancer." Annual meeting of Japan Society of Clinical Oncology, Fukuoka, Japan. October 26, 2019 (2019)
  • "Ethical guidelines for clinical research in US." Annual meeting of Japan Society of Clinical Oncology, October 22, 2016, Yokohama, Japan. (2016)
  • "Lung cancer patients and their employment," Annual meeting of Japan Lung Cancer Society, November 16, 2014, Kyoto, Japan (2014)

Service Activities:

  • ; IRB at University of Kansas, UB (2014–present)
  • Journal of Cancer Metastasis and Treatment; Junior editor
  • Translational Lung Cancer Research; Reviwer
  • Frontiers in oncology; Topic editor

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

100 High St
Suite D2-76
Buffalo, New York 14203
takefumi@buffalo.edu

This faculty member is affiliated with UBMD, practicing physicians who are also professors in the Jacobs School.

View this physician on UBMD